Management of Refractory Pediatric Ringworm

Diagnosis and Initial Assessment

• Obtain fungal culture and KOH microscopy to confirm dermatophyte infection and identify the causative species, which guides therapy selection. 1
• Distinguish scalp infection (tinea capitis) from body infection (tinea corporis) because scalp disease requires oral antifungal agents, whereas limited body disease may respond to topical therapy. 2

Why Topical Clotrimazole Often Fails

• Topical agents alone cannot achieve mycological cure in tinea capitis due to inadequate penetration of hair follicles. 1
• Common contributors to treatment failure include poor adherence, suboptimal drug absorption, resistant organisms, and reinfection from contacts or fomites. 3

First‑Line Oral Therapy for Tinea Capitis

• Terbinafine – preferred for Trichophyton infections:
  
  • < 20 kg: 62.5 mg once daily
  • 20–40 kg: 125 mg once daily
  • > 40 kg: 250 mg once daily
  • Duration: 2–4 weeks. 3
• Griseofulvin – preferred for Microsporum infections:
  
  • < 50 kg: 15–20 mg/kg/day divided doses
  • > 50 kg: 1 g daily
  • Duration: 6–8 weeks. 3

Second‑Line Oral Therapy (If No Clinical Improvement)

• Itraconazole – 50–100 mg daily or 5 mg/kg/day for 2–4 weeks; active against both Trichophyton and Microsporum species. 3

Systematic Approach to Persistent Infection

• Verify patient adherence and correct application technique before escalating therapy. 3
• Screen household members and close contacts for asymptomatic carriers, especially for anthropophilic species such as T. tonsurans. 4
• Decontaminate shared items (combs, brushes, hats) with bleach or 2 % sodium hypochlorite solution. 4
• If clinical signs improve but mycological tests remain positive, extend treatment an additional 2–4 weeks. 3

Monitoring and Defining Cure

• The therapeutic endpoint is mycological cure; repeat KOH or culture until negative results are obtained. 2

Key Therapeutic Principles

• Oral systemic therapy is mandatory for achieving mycological cure in tinea capitis; topical monotherapy is insufficient. 2
• Terbinafine’s efficacy is limited against Microsporum species in pre‑pubertal children; griseofulvin should be used instead. 2
• Children receiving appropriate therapy may continue attending school; exclusion is unnecessary. 4

Species‑Specific Recommendations

• Trichophyton infections respond best to terbinafine. 1
• Microsporum infections respond best to griseofulvin. 2
• Empiric therapy should be guided by local epidemiology while awaiting culture results. 1